Literature DB >> 11807735

The structure and function of the helical heart and its buttress wrapping. VI. Geometric concepts of heart failure and use for structural correction.

G D Buckberg1, H C Coghlan, F Torrent-Guasp.   

Abstract

The macroscopic basis for congestive heart failure is defined as conversion of a helical heart, whereby the apical loop fiber angle orientation that produces a 60% ejection fraction becomes more transverse to develop a spheric configuration. The geometric consequence is flattening of the apical loop architecture, so that the 15% shortening can produce only 30% ejection fraction. The fundamental shape change is alteration of normal relationships between the transverse basal loop and oblique apical loop, to make the apical loop become more basal through more transverse fiber orientation. These fundamental architectural changes are then used to evolve new procedures that restore a more normal, helical, ventricular architecture in ischemic and dilated cardiomyopathy. Direct intraoperative ventricular methods underlie surgical ventricular restoration or endoventricular surgical patch plasty procedures, the Batista procedure, and Pacopexy. These intraventricular objectives are then compared with external approaches without ventriculotomy (ie, reimplantation of cells, pericardial sleeve (acorn), surface radiofrequency ablation, and the myocor approaches). A survey of current direct ventricular clinical results that improve the underlying nondamaged muscle (ie, remote segment) is defined, and related to timing of procedures directed at rebuilding more normal ventricular shape before irreversible collagen and fibrosis develop. The overall intent is to convert the spheric heart into an elliptic configuration. Novel concepts are introduced to suggest an internal ventricular patch can be used as an intercavitary curtain, through covering nonscarred septal muscle (ie, normal but distended) to amplify left ventricular function through producing a more helical structure. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11807735     DOI: 10.1053/stcs.2001.29959

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  7 in total

1.  Reconstruction of myocardial tissue motion and strain fields from displacement-encoded MR imaging.

Authors:  Yi Liu; Han Wen; Robert C Gorman; James J Pilla; Joseph H Gorman; Gerald Buckberg; Shawn D Teague; Ghassan S Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-26       Impact factor: 4.733

Review 2.  Ventricular structure and surgical history.

Authors:  Gerald Buckberg
Journal:  Heart Fail Rev       Date:  2004-10       Impact factor: 4.214

3.  Functional ischemic mitral regurgitation in anterior ventricular remodeling: results of surgical ventricular restoration with and without mitral repair.

Authors:  L Menicanti; M DiDonato; S Castelvecchio; C Santambrogio; V Montericcio; A Frigiola; G Buckberg
Journal:  Heart Fail Rev       Date:  2004-10       Impact factor: 4.214

4.  Role of site selection for left ventriculoplasty to treat idiopathic dilated cardiomyopathy.

Authors:  Hisayoshi Suma; Tadashi Isomura; Taiko Horii; Gerald Buckberg
Journal:  Heart Fail Rev       Date:  2004-10       Impact factor: 4.214

Review 5.  Surgical left ventricular reconstruction.

Authors:  Tadashi Isomura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-05-06

6.  The Prognostic Value of Left Ventricular Mechanical Dyssynchrony Derived from Cardiac MRI in Patients with Idiopathic Dilated Cardiomyopathy.

Authors:  Yangjie Li; Xiumin Liu; Yuanwei Xu; Weihao Li; Siqi Tang; Xiaoyue Zhou; Jiayu Sun; Qing Zhang; Yuchi Han; Yucheng Chen
Journal:  Radiol Cardiothorac Imaging       Date:  2021-08-26

7.  Enhanced gap junction expression in myoblast-containing engineered tissue.

Authors:  Sureshkumar Perumal Srinivasan; Klaus Neef; Philipp Treskes; Oliver J Liakopoulos; Christof Stamm; Douglas B Cowan; Navid Madershahian; Elmar Kuhn; Ingo Slottosch; Thorsten Wittwer; Thorsten Wahlers; Yeong-Hoon Choi
Journal:  Biochem Biophys Res Commun       Date:  2012-05-10       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.